Our VP of Business Development, Kevin Vos, Ph.D., attended the BIO International Convention from June 3-6, representing VoxCell BioInnovation at this prestigious event. We are thrilled to announce that VoxCell was selected to participate in the Start-Up Stadium on June 5 from 2-4pm PST.
In a thrilling dragon’s den-style pitch, Kevin had 5 minutes to present our innovative solutions, followed by 5 minutes of Q&A with industry experts and investors. This opportunity allowed us to showcase our cutting-edge bioprinting technologies and connect with key players in the biotech ecosystem.
The BIO International Convention is the largest and most comprehensive event for biotechnology, bringing together more than 18,500 industry leaders from around the globe. Whether you are from a public pharmaceutical company, biotech startup, academia, non-profits, government, or are a researcher, business development professional, or investor, BIO is the place to make valuable connections and build relationships.
